Vascular neurology is the medical subspecialty focused on diseases of the blood vessels that supply the brain and spinal cord. Its core territory is stroke, both the kind caused by a blocked artery and the kind caused by a burst one, but the field reaches well beyond acute emergencies to include conditions like cerebral venous thrombosis, vascular malformations, inherited small-vessel diseases, and the cognitive decline that accumulates from years of vascular damage. The subspecialty sits at the intersection of neurology, cardiology, and interventional radiology, and its scope has expanded considerably since dedicated stroke centers and advanced brain imaging became standard in the early 2000s.
Ischemic Stroke and Why Minutes Matter
Ischemic stroke, caused by a blood clot blocking an artery in the brain, accounts for roughly 85 percent of all strokes and is the condition most central to vascular neurology. When an artery is blocked, a zone of brain tissue dies almost immediately because blood flow drops too low to sustain it. Surrounding that dead core is a region called the ischemic penumbra: tissue that is still structurally intact but has stopped functioning because it is receiving just enough blood to survive, for now. In animal models, this penumbra has been identified for up to three hours after the blockage, while in some human patients it can persist for as long as 48 hours, depending on how much collateral blood flow a person has.1PubMed. Salvaging the ischaemic penumbra: more than just reperfusion?
The penumbra is what makes “time is brain” more than a slogan. Experimental data in animal models show that after a major artery is blocked, infarcted tissue expands rapidly in the first hours, with most of the salvageable penumbra being consumed within 60 to 90 minutes if blood flow is not restored.2PubMed Central. Targeting ischemic penumbra: part I – from pathophysiology to therapeutic strategy That speed of tissue loss is why stroke is treated as an emergency comparable to a heart attack, and it explains the urgency that drives nearly every clinical decision in acute vascular neurology.
Acute Treatments for Blocked Arteries
The two main weapons for reopening a blocked brain artery are intravenous thrombolysis (a clot-dissolving drug given through a vein) and mechanical thrombectomy (a catheter-based procedure that physically pulls the clot out). Thrombectomy is the standard treatment for large vessel occlusions and was traditionally offered within six hours of symptom onset.3PubMed Central. Extended Window for Stroke Thrombectomy Landmark trials in 2015 proved that thrombectomy dramatically improved outcomes, and subsequent trials pushed the treatment window further by using advanced brain imaging to identify patients who still had salvageable tissue.
Today, thrombectomy can be performed up to 24 hours after symptoms begin in carefully selected patients whose brain scans show a favorable ratio of threatened-but-viable tissue to already-dead tissue. In one study comparing patients treated in early and late time windows, outcomes were comparable: about 42 percent of late-window patients achieved a good outcome, not statistically different from the 53 percent in the early window.4PubMed Central. Mechanical Thrombectomy Up to 24 Hours in Large Vessel Occlusions and Infarct Velocity Assessment The catch is that this extended window depends on sophisticated perfusion imaging that not all hospitals can provide around the clock. Recent trials of intravenous thrombolysis in the late window have shown it can benefit imaging-selected patients when thrombectomy is not available, addressing a critical gap in health systems that lack 24/7 interventional neurology coverage.5PubMed Central. Late-window reperfusion in imaging-selected ischemic stroke: interpreting thrombolysis and mechanical thrombectomy trials
Perfusion imaging is the technology that makes these extended-window decisions possible. CT or MRI perfusion scans map blood flow across the brain in real time, distinguishing the already-dead core from the penumbra that might still be saved. Research has validated specific thresholds on these scans that predict whether a patient will benefit from intervention. In large vessel occlusions, a cerebral blood flow below about 30 percent of normal identifies the core, while delays in blood arrival greater than a few seconds map the penumbra.6PubMed. Whole-Brain CT Perfusion to Quantify Acute Ischemic Penumbra and Core Newer work is refining these thresholds for smaller, more distal blockages, where the existing rules of thumb may not apply as neatly.7PubMed Central. Redefining Ischemic Core, Penumbra, and Target Mismatch on Perfusion Imaging in Acute Anterior Distal Medium Vessel Occlusion
Transient Ischemic Attack
A transient ischemic attack, commonly called a TIA or “mini-stroke,” occurs when blood flow to part of the brain is temporarily disrupted without leaving permanent damage on imaging. The symptoms are similar to a full stroke, such as sudden weakness on one side, slurred speech, or vision loss, but they typically resolve within minutes to hours. TIAs are a core concern for vascular neurologists because they are powerful warning signals: roughly one-third of people who have a TIA will go on to have a full stroke if the underlying cause is not identified and treated.8PubMed Central. Risk factors of transient ischemic attack: An overview The urgent workup after a TIA, which includes brain imaging, vessel imaging, and heart monitoring, is one of the most common reasons a person is referred to a vascular neurologist.
Hemorrhagic Stroke and Subarachnoid Hemorrhage
Not all strokes involve a blocked artery. In hemorrhagic stroke, a blood vessel bursts and bleeds into or around the brain. One particularly dangerous subtype is aneurysmal subarachnoid hemorrhage, where a weakened bulge on a brain artery (an aneurysm) ruptures and spills blood into the space surrounding the brain. Beyond the immediate damage from the bleed itself, these patients face a secondary threat called vasospasm, a pathological constriction of brain arteries triggered by blood irritating the vessel walls. Radiographic evidence of vasospasm appears in roughly half to 70 percent of patients after subarachnoid hemorrhage, and about 30 percent of those develop the kind of severe constriction that causes visible neurological deficits.9PubMed Central. Vasospasm-Related Death after Aneurysmal Subarachnoid Hemorrhage: A Retrospective Case–Control Study
Vasospasm-related brain damage, sometimes called delayed cerebral ischemia, is essentially a stroke caused by the hemorrhage itself. In one study of patients who survived the initial rupture, 37 percent developed delayed cerebral ischemia, and in about 22 percent of total patients it led to permanent disability or death.10PubMed. Aspirin and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage Managing this delayed phase, through close monitoring in a neurointensive care unit and interventions to widen the narrowed arteries, is a major part of vascular neurology’s overlap with neurosurgery and critical care.
Vascular Malformations
The brain can harbor abnormal tangles or clusters of blood vessels that a person may live with for decades without knowing. Two of the most important types that vascular neurologists manage are arteriovenous malformations (AVMs) and cavernous malformations.
An AVM is an abnormal connection between arteries and veins in the brain, bypassing the normal capillary bed. The main risk is hemorrhage. A large multicenter study found that unruptured AVMs bleed at a rate of about 1.4 percent per year, which sounds small until you consider that this risk compounds over a lifetime. Older age at diagnosis, the presence of associated aneurysms, and a deep or cerebellar location all independently raised the risk of a first bleed.11PubMed Central. Risk of Future Hemorrhage From Unruptured Brain Arteriovenous Malformations: The Multicenter Arteriovenous Malformation Research Study (MARS) Whether to treat an unruptured AVM or monitor it is one of the more contentious debates in the field, because treatment itself carries risks.
Cavernous malformations are clusters of abnormally dilated, thin-walled capillaries that can leak or bleed. They tend to be smaller and lower pressure than AVMs, and many are found incidentally on brain scans done for other reasons. Research into what predicts bleeding has found that larger lesion size is the strongest risk factor; in one study, lesions over a certain volume were about three times more likely to have bled than smaller ones.12PubMed. Bleeding risk evaluation in cerebral cavernous malformation, the role of medications, and hemorrhagic factors: a case-control study Most small, incidentally discovered cavernous malformations are simply monitored over time with periodic imaging.
Rare Arteriopathies and Genetic Vessel Diseases
Some of the most challenging conditions in vascular neurology are diseases of the blood vessel walls themselves rather than the clots or bleeds they produce. Moyamoya disease, for example, causes a progressive narrowing of the large arteries at the base of the brain, forcing the body to grow a fragile network of tiny collateral vessels that look, on angiography, like a puff of smoke (the Japanese word “moyamoya”). It is rare but carries high morbidity and mortality, and there is still no consensus on unified diagnostic criteria or treatment guidelines.13PubMed. Management of Inherited CNS Small Vessel Diseases: The CADASIL Example: A Scientific Statement From the American Heart Association
CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) is the most common inherited form of cerebral small-vessel disease. It is caused by mutations in the NOTCH3 gene on chromosome 19 and leads to recurrent small strokes, migraine with aura, mood disturbances, and eventually vascular dementia.14PubMed Central. NOTCH3 and CADASIL syndrome: a genetic and structural overview The disease shows considerable variability in when symptoms start and how fast they progress, which is only partly explained by differences in the specific NOTCH3 mutation a person carries.13PubMed. Management of Inherited CNS Small Vessel Diseases: The CADASIL Example: A Scientific Statement From the American Heart Association There are no disease-modifying treatments yet, so management focuses on controlling vascular risk factors and monitoring for cognitive decline.
Cerebral Venous Thrombosis
Most people associate stroke with arterial problems, but the brain’s veins can clot too. Cerebral venous thrombosis (CVT) occurs when a blood clot forms in one of the large veins or venous sinuses that drain blood from the brain. It presents very differently from arterial stroke, with symptoms that can include severe headache, seizures, and sometimes gradual confusion rather than the sudden one-sided weakness people expect from a stroke.15PubMed. Diagnosis and Management of Cerebral Venous Thrombosis: A Scientific Statement From the American Heart Association
CVT disproportionately affects younger people and women of reproductive age, often in the setting of hormonal contraceptive use, pregnancy, or an underlying tendency to form blood clots. The mainstay of treatment, somewhat counterintuitively, is blood thinners. Even when the clot has caused bleeding in the brain, anticoagulation has repeatedly been shown to be safe and effective, because the clot itself drives further damage if left untreated.16Journal of Neurosurgery. From presentation to follow-up: diagnosis and treatment of cerebral venous thrombosis With prompt treatment, most CVT patients recover well, though a high index of suspicion is needed because the atypical presentation means it is frequently missed or diagnosed late.
Inflammation of Brain Blood Vessels
Primary central nervous system (CNS) vasculitis is one of the rarest and most difficult diagnoses in vascular neurology. It involves inflammation of the blood vessel walls within the brain or spinal cord, with no systemic vasculitis elsewhere in the body. The condition is extremely uncommon, with estimated incidence rates of fewer than one to about two cases per million people.17PubMed Central. Cerebral vasculitis in adults: what are the steps in order to establish the diagnosis? Red flags and pitfalls
Diagnosing it is a process of exclusion and detective work. There is no single blood test or scan that confirms it. MRI of the brain is abnormal in the vast majority of cases but the abnormalities are nonspecific, and spinal fluid analysis shows abnormalities about three-quarters of the time, again without anything distinctive.18Practical Neurology. The diagnosis of primary central nervous system vasculitis Brain biopsy remains the gold standard and yields a definitive diagnosis in roughly 60 percent of cases.17PubMed Central. Cerebral vasculitis in adults: what are the steps in order to establish the diagnosis? Red flags and pitfalls Newer imaging techniques like vessel wall MRI, which shows inflammation as a characteristic pattern of enhancement in the artery walls, are providing additional diagnostic clues. In one study, intense, concentric enhancement was found in the vast majority of confirmed CNS vasculitis cases, with the anterior circulation most commonly affected.19PubMed Central. The Contribution of Vessel Wall Magnetic Resonance Imaging to the Diagnosis of Primary and Secondary Central Nervous System Vasculitis
Vascular Cognitive Impairment
Stroke does not always announce itself with dramatic symptoms. Repeated small strokes and chronic damage to the brain’s white matter from years of poorly controlled blood pressure, diabetes, or other vascular risk factors can quietly erode thinking ability. This spectrum of damage, called vascular cognitive impairment, ranges from subtle executive dysfunction (difficulty planning, organizing, and multitasking) to full vascular dementia. The connection between small deep strokes and white matter changes and this type of cognitive decline is well established.20PubMed Central. Subcortical ischemic vascular dementia Vascular neurologists are increasingly involved in identifying and managing this condition, which is the second most common cause of dementia after Alzheimer’s disease and frequently coexists with it.
Preventing a Second Stroke
Once a person has had a stroke or TIA, a significant part of a vascular neurologist’s role shifts to preventing the next one. The choice of blood-thinning medication depends heavily on why the stroke happened in the first place. For strokes caused by large artery atherosclerosis or small vessel disease, antiplatelet drugs are generally preferred. For strokes linked to atrial fibrillation, where the heart’s irregular rhythm allows clots to form in the left atrium and travel to the brain, anticoagulation is the standard approach.21PubMed. Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke: JACC State-of-the-Art Review Atrial fibrillation is one of the strongest individual risk factors for stroke, and the intersection of cardiac rhythm management and cerebrovascular prevention represents a major area where vascular neurology meets cardiology.
A particularly tricky category is embolic stroke of undetermined source, where imaging confirms the stroke was caused by an embolism but no clear origin like atrial fibrillation or severe artery narrowing is found. Several large trials have tested whether anticoagulants are better than antiplatelets in these patients, and the overall answer has been no: across trials, anticoagulation did not significantly reduce recurrent strokes compared with antiplatelet therapy. One exception emerged in patients who had a patent foramen ovale, a small hole between the heart’s upper chambers. In that subgroup, anticoagulation did lower the risk of recurrent stroke.22PubMed Central. Anticoagulation vs Antiplatelets Across Subgroups of Embolic Stroke of Undetermined Source: A Meta-Analysis of Randomized Controlled Trials Sorting patients into the right prevention strategy, sometimes deploying long-term heart monitors to catch intermittent atrial fibrillation that initial testing missed, is exactly the kind of nuanced, longitudinal work that defines vascular neurology beyond the acute phase.
Disparities in Who Gets Treated
Access to the life-saving treatments vascular neurology offers is not equally distributed. Research using large national databases has shown that Black patients were significantly less likely to receive mechanical thrombectomy than white patients, even after accounting for other factors, and those in the lowest income bracket were similarly disadvantaged. Higher income and private insurance predicted both greater use of thrombectomy and better outcomes, while Black race independently predicted worse outcomes.23PubMed Central. Racial and Socioeconomic Disparities in the Use and Outcomes of Endovascular Thrombectomy for Acute Ischemic Stroke These disparities are shaped by a tangle of factors including socioeconomic status, education, geographic proximity to stroke centers, and quality of care received.24PubMed Central. Racial and Ethnic Disparities in Stroke Incidence and Outcomes The field is increasingly grappling with how to deliver advanced stroke care equitably, recognizing that a treatment only works for the people who actually receive it.
When Stroke Happens in Children
Stroke in children is uncommon but far from nonexistent, and it presents a distinct set of challenges that vascular neurologists and pediatric neurologists must navigate together. The causes in children differ markedly from those in adults. Rather than the atherosclerosis and atrial fibrillation that dominate adult stroke, pediatric ischemic stroke is more often linked to non-atherosclerotic arteriopathies (diseases of the vessel wall that are not plaque-related), congenital heart defects that allow clots to reach the brain, and blood disorders like sickle cell disease.25PubMed Central. Acute ischemic stroke in childhood: a comprehensive review
Diagnosis in children is complicated by the fact that symptoms often look different from the classic adult stroke presentation. A child may present with headache alone or even no obvious clinical symptoms. And unlike in adult stroke, there are no validated guidelines for thrombolytic or endovascular treatment in pediatric patients, leaving clinicians to extrapolate from adult data and make case-by-case decisions.25PubMed Central. Acute ischemic stroke in childhood: a comprehensive review This evidence gap is one of the more urgent unmet needs in the field.
Rehabilitation and the Brain’s Capacity to Rewire
Vascular neurology does not end when the acute crisis is over. Recovery from stroke depends on neuroplasticity, the brain’s ability to reorganize its connections and recruit undamaged areas to take over lost functions. Understanding how this rewiring works and how to enhance it is a growing frontier that bridges vascular neurology with rehabilitation medicine. Several models describe how recovery unfolds. In some cases, nearby brain regions take over the functions of the damaged area. In others, the balance of activity between the two hemispheres of the brain shifts and needs to be rebalanced for optimal recovery.26PubMed. Enhancing Neuroplasticity for Post-Stroke Motor Recovery: Mechanisms, Models, and Neurotechnology
Newer technologies are trying to harness these mechanisms more precisely. Brain-computer interfaces paired with functional electrical stimulation, for example, allow a stroke patient’s brain activity to directly trigger movements of a paralyzed limb, reinforcing the neural pathways needed for recovery. Longitudinal research on this approach in elderly stroke patients has shown improvements in motor function, daily living skills, and cognitive scores, with measurable changes in brain connectivity patterns. The data suggest an optimal treatment window of roughly 3 to 12 months after the stroke, and patients under 70 with some residual capacity for plasticity tend to respond best.27PubMed Central. Long-Term Brain-Computer Interface Functional Electrical Stimulation Enhances Neuroplasticity and Functional Recovery in Elderly Stroke These technologies remain largely experimental, but they illustrate the direction the field is moving: from simply saving brain tissue in the acute phase to actively rebuilding function afterward.